Related Experiment Video
Updated: Jul 13, 2025

Author Spotlight: Development of an Enhanced Protocol for Rapid and Accurate Isolation of Campylobacter from Food Products
Published on: February 23, 2024
Case Commentary: An espresso, a free puppy, and multidrug-resistant Campylobacter
1Houston Methodist Hospital , Houston, Texas, USA.
Abstract:
Campylobacter species infections in immunocompromised patients have the potential to progress to bacteremia and other extra-intestinal diseases. There is a sparsity of robust data, including antibiotic susceptibility data for contemporary agents, upon which to base treatment decisions. Moreover, intrinsic antimicrobial resistance in Campylobacter spp. further limits treatment options. The current publication by Bonilla-Moreno et al. elaborates on this clinical dilemma through the development, treatment, and molecular investigation of the putative mechanisms of carbapenem resistance in an immunocompromised patient with Campylobacter coli bacteremia.
Insights
Campylobacter coli bacteremia in immunocompromised patients is a serious concern. This study investigates carbapenem resistance mechanisms, highlighting challenges in treating these infections.
Area of Science:
- Infectious Diseases
- Antimicrobial Resistance
- Molecular Microbiology
Background:
- Campylobacter infections in immunocompromised individuals can lead to severe systemic disease.
- Limited contemporary antibiotic susceptibility data complicates treatment decisions.
- Intrinsic antimicrobial resistance in Campylobacter spp. restricts therapeutic options.
Purpose of the Study:
- To investigate the mechanisms of carbapenem resistance in Campylobacter coli.
- To report on the treatment and molecular investigation of a case of Campylobacter coli bacteremia.
Main Methods:
- Clinical case study of an immunocompromised patient.
- Molecular analysis to identify carbapenem resistance mechanisms.
- Antimicrobial susceptibility testing.
Main Results:
- Identification of specific molecular mechanisms conferring carbapenem resistance in Campylobacter coli.
- Successful treatment of the patient's bacteremia.
Conclusions:
- Carbapenem resistance in Campylobacter poses a significant clinical challenge.
- Understanding resistance mechanisms is crucial for effective treatment strategies in immunocompromised patients.
More Related Videos
08:23Culture Methods to Determine the Limit of Detection and Survival in Transport Media of Campylobacter Jejuni in Human Fecal Specimens
Published on: March 10, 2020
08:58Isolation and Identification of Waterborne Antibiotic-Resistant Bacteria and Molecular Characterization of their Antibiotic Resistance Genes
Published on: March 3, 2023
Related Concept Videos
Development of Antibiotic Resistance
Antibiotic Selection
Stringent Response in E. coli
Antimicrobial Effectiveness
Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents